Phase 1 Study for Safety of ACHN-490

PHASE1CompletedINTERVENTIONAL
Enrollment

39

Participants

Timeline

Start Date

January 31, 2009

Primary Completion Date

October 31, 2009

Study Completion Date

October 31, 2009

Conditions
Healthy
Interventions
DRUG

ACHN-490 Injection vs placebo

Escalating doses beginning with test dose given once, followed by 4 mg/kg with a single dose then multiple dose. Dose escalation to continue up to 15 mg/kg as long as the treatment is deemed safe.

Trial Locations (1)

49007

Jasper Clinic, Kalamazoo

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Achaogen, Inc.

INDUSTRY

NCT00822978 - Phase 1 Study for Safety of ACHN-490 | Biotech Hunter | Biotech Hunter